Francesca Barone

机构：Brigham and Women's Hospital, Queen Elizabeth Hospital Birmingham, University Hospital Zurich, Center for Neuro-Oncology, Dana-Farber Cancer Institute, National Eye Institute, Celldex Therapeutics (United States), Candel Therapeutics (United States), University of Calabria, University of Birmingham · ORCID：0000-0002-5287-9614

发表论文 359 篇 · 总被引 9147 次 · h-index 49

代表论文

• Primary Sjögren’s Disease: a review of unmet need, outcome measures, therapeutic advances and health economic impacts. Lessons from the NEw Clinical Endpoints in primary Sjögren’s Syndrome: an Interventional Trial based on stratifYing patients (NECESSITY) Innovative Health Initiative (IHI) (2025 · Annals of the Rheumatic Diseases · 被引 24)
• Serial multiomics uncovers anti-glioblastoma responses not evident by routine clinical analyses (2025 · Science Translational Medicine · 被引 16)
• A multi-institutional phase 1 clinical trial exploring upfront multimodal standard of care and combined immunotherapies for newly diagnosed glioblastoma (2025 · Neuro-Oncology · 被引 11)
• Phase 3, randomized, placebo-controlled clinical trial of CAN-2409+prodrug in combination with standard of care external beam radiation (EBRT) for newly diagnosed localized prostate cancer. (2025 · Journal of Clinical Oncology · 被引 7)
• iPSC-RPE patch restores photoreceptors and regenerates choriocapillaris in a pig retinal degeneration model (2025 · JCI Insight · 被引 7)
• Author Correction: Distinct fibroblast subsets drive inflammation and damage in arthritis (2025 · Nature · 被引 1)